[Clinical effect of midodrine hydrochloride on the patients with urinary incontinence].
The effects of midodrine hydrochloride (Brand name: Metligine tablet 2 mg, Manufacturer: Taisho Pharmaceutical Co., Ltd.), alpha-1 adrenalin receptor agonist against urinary incontinence was examined on 5 female patients with stress urinary incontinence and 5 male urinary incontinent patients of various causes. Metligine was administered in the dose of 4 mg daily for 2 to 4 weeks. Eighty per cent of the stress incontinent patients showed improvement and five incontinent male also showed improvement of symptoms. No side effects were recognized.
Nito
H
H
Department of Urology, Musashino Red Cross Hospital.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008879:Midodrine / Q000627:therapeutic use*; D013607:Tablets; D014549:Urinary Incontinence / Q000188:drug therapy*; D014550:Urinary Incontinence, Stress / Q000188:drug therapy
D013607:Tablets; D008879:Midodrine